Octyl Gallate and Gallic Acid Isolated from Terminalia bellirica Circumvent Breast Cancer Progression by Enhancing

Periyasamy Vijayalakshmi1,2, Sabapathy Indu1,2, Christopher Ireen1,2

  • 1DBT-BIF Centre, Holy Cross College (Autonomous), Tiruchirappalli, Tamil Nadu, India.

Insights

Octyl gallate (OG) and gallic acid (GA) from T. bellirica show significant anti-cancer effects against breast cancer progression. These natural compounds effectively induce apoptosis and restore antioxidant levels in preclinical models.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Breast cancer remains a leading cause of mortality globally, necessitating the development of novel, cost-effective chemoprevention strategies.
  • Natural products offer a promising avenue for discovering new therapeutic agents with potentially fewer side effects.
  • Terminalia bellirica is a medicinal plant with a history of traditional use, suggesting potential bioactive compounds.

Purpose of the Study:

  • To evaluate the chemopreventive efficacy of octyl gallate (OG) and gallic acid (GA), isolated from T. bellirica, against breast cancer.
  • To investigate the molecular mechanisms underlying the anti-cancer effects of OG and GA in breast cancer cell lines and an animal model.
  • To assess the potential of OG and GA as natural chemotherapeutic agents for breast cancer prevention.

Main Methods:

  • In vitro studies using breast cancer cell lines (MCF-7 and MDA-MB-231) to analyze apoptosis-related protein expression via Western blot.
  • In vivo studies using a 7,12-dimethylbenz(a)anthracene (DMBA)-induced Sprague-Dawley rat model of breast cancer.
  • Assessment of body weight changes, hematological indices, tumor markers (CEA, CA 15.3), oxidative stress (TBARS), and antioxidant enzyme activity (SOD, CAT, GPx) in the animal model.
  • Computational molecular interaction studies and tissue histology to further elucidate the therapeutic mechanisms.

Main Results:

  • OG and GA significantly altered apoptotic protein expression in breast cancer cell lines, downregulating Bcl-2 and Bcl-xL while upregulating Bak and Bax.
  • In the DMBA-induced rat model, OG and GA administration led to normalized body weight and hematological profiles.
  • Treatment with OG and GA significantly reduced serum tumor markers (CEA, CA 15.3) and oxidative stress (TBARS), while restoring antioxidant enzyme activity (SOD, CAT, GPx) in mammary tissue.
  • Histological analysis confirmed the therapeutic role of OG and GA, supporting their chemopreventive potential.

Conclusions:

  • Octyl gallate and gallic acid exhibit significant chemopreventive properties against breast cancer progression.
  • These compounds exert their effects by modulating the intrinsic apoptotic signaling pathway.
  • OG and GA demonstrate potential as natural chemotherapeutic agents for breast cancer prevention and warrant further investigation.